VEDANTA BIOSCIENCES, INC. — Form D/A

VEDANTA BIOSCIENCES, INC. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2019-03-28. The offering totals $50.0M, of which $39.9M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
John LaMattinaDirectorCambridge, MA
Charles SherwoodDirectorCambridge, MA
Susan DillonDirectorCambridge, MA
Martin HeideckerDirectorCambridge, MA
Neil TiwariDirectorCambridge, MA
Curt LaBelleDirectorCambridge, MA
Daniel CoutoExecutive OfficerCambridge, MA
Bernat OlleDirectorCambridge, MA
Bernat OlleExecutive OfficerCambridge, MA
Mark MullikinExecutive OfficerCambridge, MA
Bennett ShapiroDirectorCambridge, MA
Troy IgnelziDirectorCambridge, MA
Jeffrey SilberExecutive OfficerCambridge, MA
Christopher M ViehbacherDirectorCambridge, MA
John L LaMattinaDirectorCambridge, MA
Daniel L CoutoExecutive OfficerCambridge, MA
Bharatt ChowriraDirectorCambridge, MA
Mark L MullikinExecutive OfficerCambridge, MA
Bennett M ShapiroDirectorCambridge, MA
Jeffrey L SilberExecutive OfficerCambridge, MA
Susan M DillonDirectorCambridge, MA
Bharatt M ChowriraDirectorCambridge, MA
Christopher ViehbacherDirectorCambridge, MA

Other filings by this issuer (6)

FiledFormOfferingSold
2024-08-05D/A$118.5M$118.5M
2023-05-02D$106.5M$106.5M
2021-08-13D$75.0M$68.4M
2019-09-19D$16.6M$8.0M
2019-05-08D/A$50.0M$45.4M
2019-02-05D$50.0M$26.7M

More